Rice Hall James & Associates LLC Sells 689 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Rice Hall James & Associates LLC lessened its holdings in Simulations Plus, Inc. (NASDAQ:SLP) by 0.9% in the third quarter, Holdings Channel reports. The institutional investor owned 76,629 shares of the technology company’s stock after selling 689 shares during the period. Rice Hall James & Associates LLC’s holdings in Simulations Plus were worth $2,454,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in SLP. US Bancorp DE raised its holdings in Simulations Plus by 37.0% during the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock worth $159,000 after purchasing an additional 1,343 shares during the last quarter. Congress Asset Management Co. raised its holdings in Simulations Plus by 22.5% during the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after purchasing an additional 37,914 shares during the last quarter. Semanteon Capital Management LP bought a new position in Simulations Plus during the 3rd quarter worth approximately $358,000. Tributary Capital Management LLC raised its holdings in Simulations Plus by 54.7% during the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after purchasing an additional 115,122 shares during the last quarter. Finally, Trust Point Inc. raised its holdings in Simulations Plus by 27.5% during the 3rd quarter. Trust Point Inc. now owns 11,994 shares of the technology company’s stock worth $384,000 after purchasing an additional 2,589 shares during the last quarter. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Trading Up 2.1 %

NASDAQ SLP opened at $27.78 on Friday. The company has a fifty day simple moving average of $32.28 and a 200 day simple moving average of $39.97. Simulations Plus, Inc. has a 12-month low of $27.22 and a 12-month high of $51.22. The company has a market cap of $555.88 million, a P/E ratio of 56.70 and a beta of 0.69.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same quarter last year, the firm posted $0.18 EPS. Simulations Plus’s revenue was up 19.9% compared to the same quarter last year. Sell-side analysts predict that Simulations Plus, Inc. will post 1.11 EPS for the current year.

Analyst Upgrades and Downgrades

SLP has been the subject of several analyst reports. JMP Securities initiated coverage on shares of Simulations Plus in a report on Tuesday, July 16th. They set a “market perform” rating for the company. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research report on Thursday, October 24th. BTIG Research reduced their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. Finally, KeyCorp initiated coverage on shares of Simulations Plus in a research report on Monday, July 29th. They set an “overweight” rating and a $47.00 price objective for the company. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Simulations Plus currently has a consensus rating of “Moderate Buy” and an average price target of $54.50.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total transaction of $625,200.00. Following the transaction, the director now directly owns 3,481,592 shares of the company’s stock, valued at $108,834,565.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 40,750 shares of company stock valued at $1,352,455 in the last three months. 20.90% of the stock is currently owned by insiders.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.